MarketGluten exorphin
Company Profile

Gluten exorphin

Gluten exorphins are a group of opioid peptides formed during the digestion of the gluten protein. These peptides work as external regulators for gastrointestinal movement and hormonal release. The breakdown of gliadin, a polymer of wheat proteins, creates amino acids that stop the gluten epitopes from entering the immune system to activate inflammatory reactions. During this process, gluten does not fully break down, thus increasing the presence of gluten exorphins. Because of this, researchers think this is what might lead to various diseases.

Names
Gluten exorphins produced by digestion of gliadin is called gliadorphin. ==Known members==
Known members
• For a key to the single-letter sequences, see . • All peptides sequences are assumed to start with NH2- and end with -COOH, unless otherwise stated. Gluten exorphin A4 • Structure: GYYP • Part of wheat glutenin sequence. Gluten exorphin A5 • Structure: GYYPT • Chemical formula: C29H37N5O9 • Molecular weight: 599.64 g/mol • Part of wheat glutenin sequence. • Chemical formula: C29H45N5O8 • Molecular weight: 591.70 g/mol Gliadorphin-7 • Structure: YPQPQPF • Part of wheat gliadin sequence. == Clinical significance ==
Clinical significance
Recent research surrounding gluten exorphins has revolved around how the peptides might play a role in various diseases and disorders. Celiac disease In response to gluten, people with celiac disease will release gluten exorphins as part of the allergic immune response. Due to the weakening of intestinal walls caused by celiac disease, some of these gluten exorphins can make their way through the lining of the intestines and are then absorbed into the bloodstream. == References ==
tickerdossier.comtickerdossier.substack.com